ArticleMolecular cancer therapeutics2025

Antineoplastic Activity of a Novel Trispecific Single-Chain Antibody Targeting the hERG1/β1 Integrin Complex and TRAIL Receptors.

Claudia Duranti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.